Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SZSE: 000766)
Health Care · Pharmaceuticals · CN
CN¥15.85
-4.35% today · -35.7% 1Y
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SZSE: 000766) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.28B and employs 1,480 people.
Over the last twelve months the share price has lost 35.7%, trading between 14.94 and 30.20.
Tweenvest scores Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd across four factors: quality 55/100, value 15/100, growth 8/100. Its strongest factor is quality.
000766 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.28B
- Revenue (TTM)
- $158.57M
- P/E
- —
- EPS
- 0.03
- Dividend yield
- —
- Beta (5Y)
- 0.57
- 52-week high
- CN¥30.20
- 52-week low
- CN¥14.94
- Avg volume (3M)
- —
- Shares outstanding
- 966.49M
- Employees
- 1,480
- Next earnings
- —
About Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. is a Chinese pharmaceutical firm actively involved in the full spectrum of drug development, from research and development to manufacturing and sales. Its therapeutic focus primarily encompasses key areas such as rheumatism, digestive health, oncology, and gynecology. The company boasts a comprehensive and diverse product portfolio. This includes a wide array of traditional Chinese medicines (TCMs), addressing conditions like gynecological issues, rheumatic and bone pain, urological disorders, detoxification needs, cardiovascular and cerebral health, digestive and respiratory ailments, diabetes, and pediatric concerns. Beyond TCMs, it also develops and markets anti-tumor drugs, both prescription and over-the-counter (OTC) medications, and conventional Western pharmaceuticals. These products are available in multiple dosage forms, including capsules, tablets, injections, and liquid preparations. Established in 1990, the company is headquartered in Tonghua, China.
- ISIN
- CNE000000735
- Founded
- 1990
- Listed since
- Apr 30, 1997
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.22 | -0.96% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.